ARPIDA LTD - A second generation start-up for the research and developmentof anti-infectives

Authors
Mukhija, S Hesterkamp, T Haldimann, A Sperisen, P Jager, J Hoffner, J Greiveldinger-Poenaru, S Schmitt, L Hampele, I Winteler, H Jezewski, A Burri, K Kompis, I Gillessen, D Islam, K
Citation
S. Mukhija et al., ARPIDA LTD - A second generation start-up for the research and developmentof anti-infectives, CHIMIA, 54(4), 2000, pp. 158-160
Categorie Soggetti
Chemistry
Journal title
CHIMIA
ISSN journal
00094293 → ACNP
Volume
54
Issue
4
Year of publication
2000
Pages
158 - 160
Database
ISI
SICI code
0009-4293(2000)54:4<158:AL-ASG>2.0.ZU;2-Q
Abstract
Arpida Ltd was founded in July 1997 as a 'second generation' start-up compa ny dedicated to the discovery and development of novel drugs for the treatm ent of infectious diseases. The company has a total staff of 23 (16 Ph.D.s) , an international scientific advisory board composed of opinion leaders in infectious diseases, and a network of drug-development companies. Arpida h as an internal infrastructure for drug discovery-employing genomics-assiste d selection of targets, screening for novel leads, and parallel synthesis f or rapid lead optimisation - and leverages partners for drug development an d clinical trials.